Literature DB >> 14641029

Exogenous and intracellularly generated sphingosine 1-phosphate can regulate cellular processes by divergent pathways.

S Spiegel1, S Milstien.   

Abstract

S1P (sphingosine 1-phosphate) is the ligand for a family of specific G-protein-coupled receptors that regulate a wide variety of important cellular functions, including vascular maturation, angiogenesis, cell growth, survival, cytoskeletal rearrangements and cell motility. However, S1P also may have intracellular functions. In this review, we discuss two examples that clearly indicate that intracellularly generated and exogenous S1P can regulate biological processes by divergent pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14641029     DOI: 10.1042/bst0311216

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  57 in total

1.  Quantitation of multiple sphingolipid classes using normal and reversed-phase LC-ESI-MS/MS: comparative profiling of two cell lines.

Authors:  M Athar Masood; Raghavendra P Rao; Jairaj K Acharya; Josip Blonder; Timothy D Veenstra
Journal:  Lipids       Date:  2011-11-29       Impact factor: 1.880

2.  Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells.

Authors:  Sonja Balthasar; Johanna Samulin; Hanna Ahlgren; Nina Bergelin; Mathias Lundqvist; Emil C Toescu; Margaret C Eggo; Kid Törnquist
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

3.  Extracellular nucleotides induce migration of renal mesangial cells by upregulating sphingosine kinase-1 expression and activity.

Authors:  S Klawitter; L P Hofmann; J Pfeilschifter; A Huwiler
Journal:  Br J Pharmacol       Date:  2007-01-02       Impact factor: 8.739

Review 4.  Novel pathways for implantation and establishment and maintenance of pregnancy in mammals.

Authors:  Fuller W Bazer; Guoyao Wu; Thomas E Spencer; Greg A Johnson; Robert C Burghardt; Kayla Bayless
Journal:  Mol Hum Reprod       Date:  2009-10-30       Impact factor: 4.025

5.  Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction.

Authors:  Che-Chung Yeh; Hongzhe Li; Deepak Malhotra; Mei-Chuan Huang; Bo-Qing Zhu; Edward J Goetzl; Donald A Vessey; Joel S Karliner; Michael J Mann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-20       Impact factor: 4.733

6.  Production of nerve growth factor enhanced in cultured mouse astrocytes by glycerophospholipids, sphingolipids, and their related compounds.

Authors:  Atsushi Furukawa; Kouzou Kita; Misao Toyomoto; Shinobu Fujii; Seiji Inoue; Kyozo Hayashi; Kiyoshi Ikeda
Journal:  Mol Cell Biochem       Date:  2007-06-19       Impact factor: 3.396

Review 7.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.

Authors:  William L Holland; Scott A Summers
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

8.  Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61.

Authors:  Nicholas Young; Dennis K Pearl; James R Van Brocklyn
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

Review 9.  Cardioprotection in ischemia/reperfusion injury: spotlight on sphingosine-1-phosphate and bradykinin signalling.

Authors:  Emmanuel Eroume A Egom; Yunbo Ke; R John Solaro; Ming Lei
Journal:  Prog Biophys Mol Biol       Date:  2010-01-18       Impact factor: 3.667

10.  An active form of sphingosine kinase-1 is released in the extracellular medium as component of membrane vesicles shed by two human tumor cell lines.

Authors:  Salvatrice Rigogliuso; Chiara Donati; Donata Cassarà; Simona Taverna; Monica Salamone; Paola Bruni; Maria Letizia Vittorelli
Journal:  J Oncol       Date:  2010-05-24       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.